Abstract
The streptozocin-induced diabetic rat model repro- duces a metabolic lesional mechanism (type I diabetes) and the usual symptoms of evoked pain. Even though the clinical relevance of the model is challenged due to the alteration of the general health condition of the animals and the lack of morphological changes in peripheral nerves, many studies have contributed to a better pathophysiological and pharma- cological understanding of painful diabetic neuropathy, to the improvement of the use of pharmacological tools and to the emergence of new therapeutic concepts.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
